SPP1 and amyotrophic lateral sclerosis: Also, the increased SPP1 levels in the plasma of ALS patients at disease diagnosis predicted shorter survival more strongly as compared to the established risk factor of bulbar onset or neurofilament level in cerebrospinal fluid, which suggests that altered perivascular fibroblast activity precedes ALS disease onset [79].